The emergence of multidrug-resistant pathogens necessitates the search for new antibiotics acting on previously unexplored targets. Nicotinate mononucleotide adenylyltransferase of the NadD family, an essential enzyme of NAD biosynthesis in most bacteria, was selected as a target for structure-based inhibitor development. To this end, the inventors have identified small molecule compounds that inhibit bacterial target enzymes by interacting with a novel inhibitory binding site on the enzyme while having no effect on functionally equivalent human enzymes.
DERUITER, JACK;BORNE, RONALD F.;MAYFIELD, CHARLES A., J. MED. CHEM., 32,(1989) N, C. 145-151
作者:DERUITER, JACK、BORNE, RONALD F.、MAYFIELD, CHARLES A.
DOI:——
日期:——
US8785499B2
申请人:——
公开号:US8785499B2
公开(公告)日:2014-07-22
N- and 2-substituted N-(phenylsulfonyl)glycines as inhibitors of rat lens aldose reductase
作者:Jack DeRuiter、Ronald F. Borne、Charles A. Mayfield
DOI:10.1021/jm00121a027
日期:1989.1
A variety of N-(phenylsulfonyl)-N-phenylglycines 5, N-(phenylsulfonyl)-2-phenylglycines 6, and N-(phenylsulfonyl)anthranilic acids 7 were prepared as analogues of the N-(phenylsulfonyl)glycine 1 aldosereductase inhibitors. In the rat lens assay, several derivatives of 5 display greater inhibitoryactivity than the corresponding glycines 1, suggesting that N-phenyl substitution enhances affinity for